Studi

CHIUSI:

“Peritoneal Mesothelioma: Optimize Outcomes by the Integration of new Prognostic Factors and Potential Therapeutic Targets in a Individualized Treatment based on Molecular Characterization and Chemosensitivity Profile on Primary Cultures.” Ricerca Finalizzata-2009-1546664 (2011-2016, € 377.500,00). Principal Investigator;
“Innovative management of patients with Diffuse Malignant Peritoneal Mesothelioma: Clinical-Diagnostic Pathway and New Therapeutic Targets.” ISS National Institute of Health (2007-2011, €140.000,00). Principal Investigator;
“Analysis of survival and biological markers in peritoneal mesothelioma managed with an innovative treatment.” AIRC 1718 (2005-2007, € 590,00). Principal Investigator;
“Evaluation of cytoreductive surgery (peritonectomy) and intra peritoneal hyperthermic perfusion in patients affected by pseudomyxoma peritonei or mesothelioma. A phase II clinical study." AIRC (1998-2000). Principal Investigator;

ATTIVI:

“Leveraging transcriptomics to enhance HIPEC performance in patients with epithelioid Diffuse Malignant Peritoneal Mesotheliomas.” Ricerca Corrente Linea 3 - Progetto Tipo B - Traiettoria B (2024, € 50.000). Associated Investigator;